Your team has a groundbreaking product, but its path to market is unclear. When a device blurs the lines between wellness, tech, and healthcare, guessing its regulatory classification is a risky strategy. You need certainty. This is precisely why the FDA 513(g) submission process exists. By submitting a 513(g) request for classification, you get a formal, written opinion directly from the agency. This isn’t just about compliance; it’s about building a solid business plan, securing investor confidence, and getting your entire team aligned on a clear, actionable regulatory strategy.
Key Takeaways
- Clarify Your Path to Market: Use a Section 513(g) request to get a formal opinion from the FDA on your product’s classification. This foundational step helps you build a solid regulatory strategy from the start, preventing expensive missteps down the road.
- Provide a Complete and Compelling Picture: Your submission’s success depends on its clarity. A detailed device description, a well-defined intended use, and draft labeling are essential for getting a specific, helpful response and avoiding a vague answer from the agency.
- Understand It’s a Strategic Choice, Not a Requirement: A 513(g) is a specific tool for classification questions and comes with user fees and potential delays. Weigh it against alternatives like a Pre-Submission meeting for testing feedback or direct market entry if you’re confident your product isn’t a device.
What Is a Section 513(g) Request?
If you’ve ever found yourself staring at your new product and wondering, “Is this technically a medical device?” you’re not alone. The lines can be blurry, especially with innovative technology, and making the wrong call can lead to serious compliance headaches. This is where a Section 513(g) Request for Information comes in. Think of it as a formal way to ask the FDA for its opinion on your product’s classification and the regulatory requirements that come with it. It’s a direct line to the agency for clarification before you commit to a specific regulatory pathway.
Submitting a 513(g) request allows you to get a written response from the agency, clarifying whether your product meets the definition of a medical device and, if so, which regulatory class it falls into (Class I, II, or III). This isn’t a product approval or clearance; it’s purely a request for information. It’s a strategic first step that provides an official perspective, helping you map out your path to market with confidence. By getting this clarity early, you can avoid investing significant time and resources in the wrong regulatory strategy. The FDA even offers a new template, called PreSTAR, to help structure these requests, making the process more straightforward for manufacturers.
How a 513(g) Request Impacts Your Medical Device
The main reason to submit a 513(g) request is to get a clear answer on which regulations apply to your device and, crucially, whether you need to file a 510(k) premarket notification. This single piece of information can completely shape your product’s journey to market. Guessing your device’s classification is a costly gamble, potentially leading to a rejected submission or, worse, enforcement action after you’ve already launched. Getting this clarification upfront can save you weeks, or even months, of work. Instead of preparing a complex 510(k) application only to find out it wasn’t necessary, the 513(g) provides a clear roadmap.
When Should You Submit a 513(g) Request?
The best time to submit a 513(g) request is when you have genuine uncertainty about your product’s regulatory status. This often happens with innovative products that don’t fit neatly into existing categories. If you’ve reviewed the FDA’s definitions and device databases and still can’t determine if your product is a device or what its classification should be, a 513(g) is your best path forward. However, it’s not always necessary. If you and your regulatory consultants have thoroughly evaluated your product and are confident it is not a medical device, you can choose to go to market without contacting the FDA. The decision hinges on your level of certainty and risk tolerance.
The Origins and Scope of 513(g) Guidance
The 513(g) process didn’t just appear out of thin air; the FDA created it to establish a clear and consistent procedure for companies seeking regulatory clarity. The official guidance document lays out the entire framework, detailing how to submit a request, what the agency’s review process looks like, and how it responds. Essentially, it’s the official rulebook for getting a straight answer from the FDA about your product. This guidance ensures that every company, regardless of size, has a standardized way to ask for information about device classification and the applicable regulatory requirements. It’s designed to remove guesswork and provide a predictable pathway for innovators who are unsure where their product fits within the FDA’s complex structure.
How It Applies to Medical Devices and Biologics
For manufacturers of medical devices and certain biologics, the 513(g) process is a critical early-stage tool. Think of it as a strategic checkpoint before you go all-in on development and marketing. Submitting a request is a smart first step because it helps you avoid expensive mistakes, like preparing for a complex premarket submission that isn’t even required. The FDA’s formal response provides the clarity needed to build a sound regulatory strategy, secure investor funding, and align your internal teams. It confirms whether your product is a device and, if so, its classification. This information directly impacts your budget, timeline, and overall path to market, making the 513(g) a powerful tool for managing risk and resources effectively.
Providing Public Feedback on the Guidance
The regulatory landscape isn’t static, and the FDA recognizes that its processes can always be improved. The agency actively encourages industry stakeholders to provide feedback on its guidance documents, including the one for Section 513(g) requests. This is your opportunity to help shape the rules you operate under. If you have suggestions or comments, you can submit them directly to the agency either online or by mail. To ensure your feedback is correctly routed, you should reference the specific docket number for this guidance, which is FDA-2010-D-0153. Participating in this process helps the FDA understand industry challenges and refine its procedures to be more efficient and clear for everyone involved.
Breaking Down the 513(g) Request Process
Getting a formal response from the FDA about your medical device might sound intimidating, but the 513(g) process is more straightforward than you think. It’s a structured way to ask the agency for information on your device’s classification and the regulatory requirements you’ll need to meet. Think of it as a formal Q&A session where you provide all the details about your product, and the FDA gives you a clear path forward. The key is to prepare a thorough and well-organized submission package. By following the established procedures for Section 513(g) requests, you can get the answers you need to move your product toward the market with confidence.
Your Step-by-Step FDA 513(g) Submission Guide
The submission process is all about clear communication. Your goal is to give the FDA everything it needs to understand your device without any back-and-forth. First, you’ll gather all the necessary documents, which we’ll cover in a moment. Next, you’ll compile them into a single, organized package. This includes paying the required user fee, which is a critical step before submission. Once your package is complete and the fee is paid, you’ll submit it to the FDA’s Document Control Center (DCC). From there, the agency takes over, and the review clock starts ticking. It’s a linear process designed to be efficient, as long as your initial submission is complete and accurate.
Submitting Electronically Through eSTAR
To make the submission process smoother, the FDA introduced an electronic tool called eSTAR (electronic Submission Template And Resource). This interactive PDF template is designed to guide you through preparing a complete and well-organized submission. Think of it as a smart checklist that ensures you don’t miss any critical information. The FDA now encourages using eSTAR for 513(g) requests because it helps standardize submissions, which can lead to a more efficient review. By using this structured format, you reduce the risk of the agency sending your request back due to missing information, saving you valuable time. For a detailed walkthrough, you can always reference the FDA’s official guidance on the process.
Building Your 513(g) Submission Package
Your submission package needs to paint a complete picture of your device for the FDA. Start with a cover letter that clearly states you’re submitting a 513(g) Request for Information. Be sure to include the device’s name, the date, and your contact details. The core of your submission will be a detailed description of the device itself—what it is, what it’s made of, and how it works. You’ll also need to describe its intended use and provide copies of any proposed labeling, instructions for use, and marketing materials. This information helps the FDA understand not just the device, but how you plan to present it to users and healthcare providers.
What Happens During the FDA Review?
Once the FDA receives your complete submission, the review process begins. The first thing the agency will do is determine if your product actually meets the definition of a medical device. If it does, the FDA will then identify its classification (Class I, II, or III) and the regulatory pathway required to bring it to market. Their formal response letter will outline whether you need to submit a premarket notification (510(k)) or a premarket approval (PMA) application. The agency’s goal is to provide this written response within 60 calendar days. This feedback is invaluable, as it gives you a clear and official roadmap for your next steps in the regulatory process.
Key Components of Your 513(g) Request
Putting together a 513(g) request is about giving the FDA a clear, comprehensive snapshot of your medical device. Think of it as building a case file. The goal is to provide enough detail for the reviewer to understand exactly what your device is, what it does, and how you plan to market it. A well-organized and thorough submission not only makes the reviewer’s job easier but also helps you get the clear guidance you need to move forward.
Your submission package should be more than just a collection of documents; it should tell a cohesive story. Every piece, from the cover letter to the draft labeling, should align and support your request. The FDA provides detailed guidance on how to format your request, which is your primary blueprint. Your package will center around four key components: a formal cover letter, a detailed description of your device and its use, proposed labeling and marketing materials, and your specific questions for the agency. Getting these elements right is the first step toward a productive interaction with the FDA.
Starting Strong: Your Cover Letter and Device ID
Your cover letter is the formal introduction to your submission. It sets the stage for everything that follows, so it needs to be clear and professional. Start by explicitly stating that you are submitting a Request for Information under Section 513(g) of the Federal Food, Drug, and Cosmetic Act. Be sure to clearly identify your device by its proprietary or common name, and use this name consistently throughout all your documents. This simple step prevents confusion and helps the reviewer keep everything organized. This is also your chance to frame the conversation and guide the reviewer’s thinking from the very beginning.
How to Clearly Describe Your Device and Its Use
This is the heart of your submission. Here, you need to provide a detailed description of your device, including its physical characteristics, materials, and mechanism of action. Explain how it works in simple, direct terms. You should also include a clear statement of its intended use, which describes the device’s purpose. Are you claiming it will diagnose, treat, or prevent a specific condition? This information is critical, as the intended use heavily influences the device’s classification and regulatory requirements. Including photographs, diagrams, or engineering drawings can be incredibly helpful for giving the reviewer a complete picture of your product.
Detailing Your Labeling and Technical Specs
The FDA doesn’t just review your device; it reviews everything you say about your device. That’s why you must include a draft of all proposed labeling. This includes the device label itself, packaging, instructions for use (IFU), and any promotional materials like brochures or website content. The claims you make in your labeling must be consistent with the intended use you described. Any discrepancy can raise red flags and complicate your review. Providing this information upfront shows the FDA you’ve thought through your marketing and are prepared to meet labeling requirements for your potential device class.
Asking the Right Questions for FDA Guidance
Your 513(g) request is your opportunity to get specific answers from the FDA. Don’t just ask, “What is our device classification?” Instead, use the cover letter to ask targeted questions and present your own assessment. You can explain why you believe your device fits into a certain regulatory category and cite similar, legally marketed devices (known as predicates) if you’ve found any. For example, you might ask, “Does the FDA concur with our assessment that this device is a Class I device, exempt from premarket notification?” This proactive approach shows you’ve done your research and helps steer the conversation toward a productive outcome.
What Will the FDA’s Response Tell You?
After you’ve submitted your 513(g) request, the waiting game begins. The FDA typically sends a formal written response within 60 days. This letter is your first official piece of feedback from the agency, and it’s packed with information that will shape your entire regulatory strategy. Think of it as a foundational document that clarifies where your device stands and what you need to do next to move toward market approval. The details in this response will help you build a clear, actionable roadmap, saving you from making costly assumptions about your product’s regulatory requirements.
Understanding Your Device’s Classification
The most important piece of information you’ll receive is the FDA’s opinion on your device’s classification. The letter will state whether your product is considered a medical device and, if so, which class it likely falls into: Class I (low risk), Class II (moderate risk), or Class III (high risk). This classification is the cornerstone of your regulatory journey, as it determines the level of scrutiny your device will face. Getting this clarity early on is the primary reason for submitting a 513(g) request, as it prevents you from pursuing the wrong, and often more expensive, regulatory path.
Decoding Recommended Regulatory Pathways
Once your device’s class is identified, the FDA’s letter will outline the recommended regulatory pathway to get it to market. For a Class I or II device, this usually means a Premarket Notification, also known as a 510(k) submission. For a high-risk Class III device, the path will likely be a more rigorous Premarket Approval (PMA) application. The response will specify which submission is required, giving you a clear direction for your next steps. This guidance is invaluable for planning your timeline, budget, and the resources needed for a successful submission.
Identifying Key Regulations and Requirements
Beyond classification and pathways, the FDA’s response will list the specific regulations that apply to your device. This can include references to the Code of Federal Regulations (CFR), general controls, and any special controls applicable to your device type. For example, the letter might point out specific performance standards, labeling requirements, or post-market surveillance expectations. This information helps you understand the full scope of your compliance obligations, ensuring you don’t overlook critical requirements as you prepare your formal market application. It’s a checklist of rules you absolutely need to follow.
What the FDA’s Response *Won’t* Tell You
It’s just as important to understand what the FDA’s letter won’t tell you. The agency’s response is non-binding, meaning it’s their current thinking but not a final, guaranteed classification. The FDA will not confirm if your device is “substantially equivalent” to another device, which is a determination made during a 510(k) review. They also won’t offer an opinion on whether your device is safe or effective, nor will they provide a specific list of studies you need to conduct. The letter is a guide, not a final verdict, which is why expert interpretation is key to planning your next move.
Specific Studies or Tests Needed for Approval
One of the biggest questions companies have is whether the FDA’s response will include a checklist of the exact tests needed for approval. The short answer is: it won’t. The purpose of a 513(g) request is strictly to get the agency’s opinion on classification and the corresponding regulatory requirements. According to the FDA’s own procedures, the response will not specify the types of nonclinical, animal, or clinical testing needed to support a future marketing application. This is because the 513(g) is not a scientific review of your device’s safety or effectiveness. It’s up to you, the manufacturer, to develop a comprehensive testing plan that proves your device meets the necessary standards for its classification.
Why the FDA Often Takes a Conservative Stance
The FDA’s response letter is a valuable guide, but it’s important to remember that it is non-binding. This means the agency’s feedback represents its current thinking based on the information you provided, not a final, legally enforceable decision. The FDA’s primary mission is to protect public health, so it takes a cautious approach. The agency won’t confirm “substantial equivalence” to another device or offer an opinion on safety and effectiveness in a 513(g) response. Those determinations are made only after a complete review of all your data in a formal submission like a 510(k) or PMA. Think of the 513(g) as a strategic signpost, not the finish line.
How Much Does a 513(g) Request Cost?
Getting clear guidance from the FDA is an investment in your product’s future, and that includes a user fee for the 513(g) process. The FDA charges for reviewing these requests to cover their administrative and review costs, as mandated by the Federal Food, Drug, and Cosmetic (FD&C) Act. The good news is that the fees are straightforward, and there are options available to help smaller businesses manage the expense. Understanding these costs upfront helps you budget properly and avoid any delays in your submission. Let’s break down what you can expect to pay and how you might be able to reduce the fee.
A Breakdown of Standard Fees and Payment
When you submit a 513(g) request, you’ll need to pay a user fee. For the fiscal year 2025, the standard fee is $7,301. This fee is a required part of the submission process, and you’ll need to include proof of payment with your request. It’s important to confirm the latest FDA user fees before you submit, as the rates are updated annually. Payment is typically made through the FDA’s online portal, and the agency provides clear instructions on how to complete the transaction. Factoring this cost into your regulatory budget from the start will keep your project on track.
When You Might Qualify for a Fee Refund
Once you’ve paid the user fee and submitted your request, you generally can’t get that money back. However, there is one specific scenario where a refund is possible. If the FDA reviews your submission and determines that it doesn’t actually qualify as a 513(g) request, they will issue a refund. This could happen if your submission is asking for something outside the scope of a classification request, like feedback on clinical trial design, which is better suited for a Pre-Submission meeting. It’s important to remember that the refund is based on the validity of your request type, not on whether you agree with the FDA’s final classification. According to the FDA’s policy, the fee is for the agency’s time and resources spent reviewing your submission.
How to Qualify for Small Business Fee Reductions
If your company qualifies as a small business, you can significantly cut the cost of your 513(g) request. The reduced fee for small businesses in fiscal year 2025 is $3,650—a nearly 50% savings. To get this discount, you must first apply for and receive a “small business designation” from the FDA. The key here is timing. You need to submit your small business application at least 60 days before you plan to send in your 513(g) request. This deadline is firm, so planning ahead is essential to ensure your eligibility for the reduced rate. It’s a simple step that can make a big difference for your budget.
Common 513(g) Submission Challenges to Prepare For
Submitting a 513(g) request can feel like a straightforward step, but the path isn’t always a straight line. Knowing the common hurdles companies face can help you plan better and manage your expectations. From unexpected delays to ambiguous responses, being prepared for the realities of the process is your best strategy for success. Let’s walk through some of the most frequent challenges and what you can do to get ahead of them. By understanding the potential pitfalls, the true nature of FDA timelines, and how to handle an uncertain outcome, you can approach your submission with confidence and a clear plan for what comes next.
Mistakes to Avoid in Your 513(g) Request
One of the biggest frustrations with the 513(g) process is the risk of getting stuck in “regulatory purgatory.” This happens when long wait times combine with a conservative or unhelpful response from the FDA, leaving you without a clear path forward. This is often the result of a submission that lacks detail or asks vague questions. If your device description is unclear or your proposed use isn’t well-defined, the FDA may provide a generic response that doesn’t give you the specific guidance you need. To avoid this, make sure your submission is meticulously prepared, leaving no room for misinterpretation.
How Long Does the FDA Review Really Take?
While the FDA’s guidance aims for a written response within 60 calendar days, the reality is often quite different. You should not build your project timeline around this goal. In a recent fiscal year, only about 25% of 513(g) requests received a response within that timeframe because the agency doesn’t seem to prioritize them over other submissions. The best way to prepare is to assume it will take longer—sometimes several months longer. Factoring this potential delay into your product development and launch schedule from the start will save you a lot of stress down the road.
A Look at On-Time Response Rate Trends
The 60-day response goal is more of a guideline than a guarantee. Data consistently shows that the FDA meets this target for only a fraction of submissions. For example, in a recent fiscal year, only about 25% of 513(g) requests received a response within the 60-day window. This isn’t a sign of a problem with your submission; it’s a reflection of the agency’s priorities. The FDA simply doesn’t treat these requests with the same urgency as other submissions, like 510(k)s or PMAs. Understanding this trend is key to setting realistic expectations and building a project timeline that can absorb these potential delays without derailing your launch plans.
Why Delays Are Common
Several factors contribute to the extended review times for 513(g) requests. First, there are no penalties for the FDA if they miss the 60-day deadline, which means these submissions often fall to the bottom of a reviewer’s to-do list. Second, these requests typically go through more levels of internal review than other submission types, adding layers of bureaucracy and time to the process. Finally, the FDA often takes a conservative stance, leaning toward stricter regulation when a product’s classification is unclear. This cautious approach requires more deliberation, further slowing down the final response. Knowing these internal dynamics helps explain why patience is a necessary part of the 513(g) process.
What to Do About Classification Uncertainty
You submit a 513(g) request because you’re not sure how your device fits into the FDA’s regulatory framework. But what happens if the FDA’s response confirms that there’s no existing classification for your product? This isn’t a dead end. In these cases, the agency will typically recommend an alternative regulatory pathway. They might suggest you pursue a De Novo classification request for novel, low-to-moderate-risk devices or even a Premarket Approval (PMA) for higher-risk products. Being aware of these potential outcomes allows you to prepare for the next steps, no matter what the FDA’s letter says.
Is a 513(g) Request Always the Right Choice?
A 513(g) request is a powerful tool, but it’s not a one-size-fits-all solution. Before you commit the time and resources, it’s smart to consider if it’s truly the best path for your product. Sometimes, another FDA program or even a direct-to-market strategy might make more sense. The key is to match your specific questions and your company’s risk tolerance to the right regulatory approach. Making this decision thoughtfully can save you from unnecessary delays and expenses down the road, ensuring you choose the most efficient route for your business.
Choosing Between a 513(g) and a Pre-Submission
It’s easy to confuse a 513(g) with a Pre-Submission, but they serve different purposes. A 513(g) is ideal for answering a fundamental question: “Is my product a medical device, and if so, how is it classified?” It’s a formal, written inquiry. In contrast, the FDA’s Pre-Submission program is designed for more in-depth, interactive feedback. You’d use a Pre-Sub when you’re confident you have a device but need guidance on your testing plan, clinical protocols, or the data you’ll need for a future marketing submission. Think of it as a strategic conversation rather than a simple Q&A.
Exploring Alternatives for FDA Feedback
While a 513(g) is a valuable tool for classification questions, it’s not your only option for getting feedback from the FDA. Depending on your level of certainty and the specific questions you have, other avenues might be more efficient or better suited to your needs. If you’re confident your product isn’t a device, for example, you can simply market it without contacting the agency at all. But if you’re looking for some level of confirmation without committing to a formal request, the FDA offers a couple of less formal, and often faster, ways to get the guidance you need. Knowing these alternatives exist helps you make a more strategic decision about how to engage with the agency.
Getting an Informal Opinion via Email
If you’re looking for a quick, informal gut check from the agency, you can send an email directly to the FDA. By writing to DeviceDetermination@fda.hhs.gov, you can ask for an informal opinion on your product. This option is completely free, and the agency aims to respond in about a week. It’s a great way to get a preliminary sense of the FDA’s thinking without the cost and time commitment of a formal submission. However, it’s critical to understand that this feedback is not legally binding. It’s simply an informal opinion, so you can’t rely on it as your final regulatory clearance.
Using the Free Pre-Submission Program
If you already know your product is a medical device but need feedback on your testing strategy, the Pre-Submission (Pre-Sub) program is an excellent choice. This is another free program where you can get detailed, interactive feedback from the FDA on your planned non-clinical and clinical studies before you start them. The response time is longer, typically around 70 days, but the goal is different. A Pre-Sub is a collaborative meeting to discuss your development plan, not a simple request for classification. It’s a strategic move to ensure your testing will generate the data the FDA needs to see in a future 510(k) or PMA submission.
Should You Skip the 513(g) and Go to Market?
In some cases, the most strategic move is to not contact the FDA at all. If you and your regulatory team have done a thorough analysis and are confident your product does not meet the legal definition of a medical device, you can proceed directly to market. This path avoids the costs and timelines of an FDA submission, but it carries its own risks. You must have a robust, well-documented rationale for your decision. If the FDA later disagrees with your assessment, you could face significant compliance actions. This approach requires a high degree of certainty and a solid regulatory foundation.
Is a 513(g) Request Worth It for You?
Deciding on a 513(g) comes down to a simple cost-benefit analysis. The primary benefit is clarity—you get a written determination from the FDA that can guide your strategy and reassure investors. However, this clarity comes at a price. The MDUFA user fees are significant, and while the FDA’s goal is to respond within 60 days, delays are common. You need to weigh the value of an official FDA opinion against the cost and potential timeline uncertainty. For a product with a truly ambiguous regulatory status, the investment is often worth it. For a more straightforward product, the resources might be better spent elsewhere.
Your Checklist for a Successful FDA 513(g) Submission
Putting together a strong 513(g) request is more than just filling out forms; it’s about building a clear, compelling case for your device. A well-prepared submission not only gets you the answers you need but also establishes a positive and professional relationship with the FDA from the start. By being thorough, clear, and strategic, you can get the most out of this process and set your product on the right path to market.
Do Your Homework and Engage the FDA Early
Think of the 513(g) process as a smart first step for your medical device. It’s your chance to get critical feedback from the FDA before you invest too heavily in a specific development or regulatory strategy. Taking the time to prepare a detailed request helps you avoid costly mistakes down the line. This early engagement demonstrates your commitment to compliance and helps you understand the device regulation and approval landscape as it applies to your specific product. A thoughtful submission shows the agency you’ve done your homework and are serious about following the correct procedures.
Why Clear and Complete Communication Is Key
Your submission package is your first formal introduction to the FDA, so clarity is key. Your application should include a cover letter, a detailed description of the device, its intended use, and any proposed labeling or marketing materials. Your cover letter should explicitly state that it’s a 513(g) request and include all your contact information. This is also your opportunity to ask specific questions or explain why you believe your device falls into a particular category. A complete and well-organized submission makes it easier for the reviewer to understand your device, which can help streamline the process. You can find the full details in the FDA’s official guidance on the 513(g) process.
How to Time Your Submission and Follow-Up
Officially, the FDA aims to provide a written response within 60 days of receiving a complete 513(g) request. However, it’s important to manage your expectations. These requests are not always the agency’s top priority, and delays are common. You should factor this potential wait time into your overall project timeline. If you haven’t heard back after the 60-day window, a polite and professional follow-up is appropriate. A strategic approach to timing and communication can help keep your submission on the radar without straining your relationship with the agency. Understanding the reality of these timelines is crucial for effective project planning.
Related Articles
- Your Guide to Regulatory Pathways for Medical Devices
- FDA Medical Device Approval Process: A Simple Guide
Frequently Asked Questions
What’s the difference between a 513(g) request and a 510(k) submission? Think of it this way: a 513(g) is the question, and a 510(k) is the application. You submit a 513(g) to ask the FDA for its opinion on whether your product is a medical device and, if so, how it should be classified. The response helps you figure out your next steps. A 510(k) is the formal submission you would prepare if the FDA determines your product is a Class II medical device that requires premarket clearance.
Is the FDA’s decision in a 513(g) response final? No, the response you receive is considered non-binding. It represents the FDA’s current thinking based on the information you provided in your request. While it’s an incredibly valuable piece of guidance that you can rely on for strategic planning, it is not a final, legally binding determination. The agency’s official classification decision is made during the review of a formal marketing application, like a 510(k) or De Novo request.
What happens if I’m confident my product isn’t a medical device? If you and your regulatory experts have thoroughly documented your reasoning and are certain your product doesn’t meet the definition of a medical device, you can choose to go to market without contacting the FDA. This approach avoids the time and fees associated with a 513(g), but it requires a high level of confidence. You must be prepared to defend your position if the FDA ever questions your product’s status down the road.
How long should I actually expect to wait for a response? The FDA’s official goal is to respond to 513(g) requests within 60 calendar days. However, you should build your project plan with the expectation that it will likely take longer. These requests are not always prioritized over other submissions, so it’s wise to anticipate a timeline of several months. Planning for this potential delay from the beginning will help you manage your development and launch schedules realistically.
Can I get help with preparing my 513(g) submission? Absolutely. While you can prepare a submission on your own, working with a regulatory consultant can make the process much smoother. An expert can help you frame your questions strategically, ensure your device description is clear and complete, and organize your package to meet the FDA’s expectations. This can improve the quality of the response you receive and give you greater confidence in your regulatory path forward.